ClinicalTrials.gov
public full text
Public Domain
Digoxin for Recurrent Prostate Cancer
The purpose of this study is to assess the effectiveness of dioxin on prohibiting prostate cancer progression as measured by PSADT (prostate-specific antigen doubling time).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PSMA-PET Registry for Recurrent Prostate Cancer#825094
- pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer#152482
- Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer#1183056
- Genistein in Treating Patients With Prostate Cancer#877183
- F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate Cancer#1281728
Record · ID 1259153
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive